CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
AcrySof® Toric IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00758550
NCT00758550Phase 4Completed
CompareCT.gov

Visual Function After Bilateral Implantation of AcrySof® Toric

Alcon Research·interventional·Posted Sep 25, 2008·Updated Mar 16, 2010

In Brief

A Phase 4 clinical trial evaluating AcrySof® Toric IOL and AcrySof Natural for Visual Function. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The objective of this study was to evaluate visual function of AcrySof Toric and AcrySof Natural Intraocular Lenses (IOLs) following implant for replacement of cataract.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Function
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 25, 2008
Enrollment StartApr 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 17.8 years ago

Interventions

AcrySof® Toric IOLdevice

AcrySof® Toric Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery

AcrySof Naturaldevice

AcrySof Natural Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery